tiprankstipranks
Immunovant (IMVT)
NASDAQ:IMVT
US Market
Holding IMVT?
Track your performance easily

Immunovant (IMVT) Technical Analysis

787 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Immunovant’s (IMVT) Moving Averages Convergence Divergence (MACD) indicator is -1.07, suggesting Immunovant is a Buy.
Immunovant’s (IMVT) 20-Day exponential moving average is 24.91, while Immunovant’s (IMVT) share price is $23.8, making it a Sell.
Immunovant’s (IMVT) 50-Day exponential moving average is 26.48, while Immunovant’s (IMVT) share price is $23.8, making it a Sell.

Immunovant (IMVT) Pivot Points

Jan 18, 2025, 08:03 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.97
21.39
22.14
23.56
24.31
25.73
26.48
Fibonacci
21.39
22.22
22.73
23.56
24.39
24.90
25.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunovant (IMVT) Moving Averages

Jan 18, 2025, 08:03 AM
Period
Simple
Exponential
MA5
23.43Buy
23.72Buy
MA10
24.12Buy
24.08Buy
MA20
25.02Sell
24.91Sell
MA50
27.00Sell
26.48Sell
MA100
28.47Sell
27.72Sell
MA200
28.56Sell
29.10Sell
Immunovant’s (IMVT) 10-Day exponential moving average is 24.08, while Immunovant’s (IMVT) share price is $23.8, making it a Buy.
Immunovant’s (IMVT) 100-Day exponential moving average is 27.72, while Immunovant’s (IMVT) share price is $23.8, making it a Sell.
Immunovant’s (IMVT) stock price is $23.8 and Immunovant’s (IMVT) 50-day simple moving average is 27.00, creating a Sell signal.
Immunovant’s (IMVT) stock price is $23.8 and Immunovant’s (IMVT) 100-day simple moving average is 28.47, creating a Sell signal.
Immunovant’s (IMVT) stock price is $23.8 and Immunovant’s (IMVT) 200-day simple moving average is 28.56, creating a Sell signal.

Immunovant (IMVT) Technical Indicators

Jan 18, 2025, 08:03 AM
Name
Value
Implied Action
RSI (14)
43.61
Neutral
STOCH (9,6)
27.61
Neutral
STOCHRSI (14)
23.05
Neutral
MACD (12,26)
-1.07
Buy
ADX (14)
22.37
Neutral
Williams %R
-50.86
Buy
CCI (14)
-66.44
Neutral
ATR (14)
1.22
-
Ultimate Oscillator
37.08
Neutral
ROC
-5.28
Sell
Immunovant’s (IMVT) Relative Strength Index (RSI) is 43.61, creating a Neutral signal.
Immunovant’s (IMVT) Trend Strength Indicator (ADX) is 22.37, creating a Neutral signal.
Immunovant’s (IMVT) Commodity Channel Index (CCI) is -66.44, creating a Neutral signal.
Immunovant’s (IMVT) Price Rate of Change (ROC) is -5.28, creating a Sell signal.

FAQ

Is IMVT a Buy, Hold, or Sell?
Based on IMVT’s technical indicators, IMVT is a Sell.
    What is IMVT’s RSI (14)?
    IMVT’s RSI (14) is 43.61, which suggests IMVT is a Neutral.
      What is IMVT’s MACD?
      IMVT’s MACD is -1.07, which suggests IMVT is a Buy.
        What is IMVT’s 5-day moving average?
        IMVT’s 5-day moving average is 23.43, which suggests IMVT is a Buy.
          What is IMVT’s 20-day moving average?
          IMVT 20-day moving average is 25.02, which suggests IMVT is a Sell.
            What is IMVT’s 50-day moving average?
            IMVT’s 50-day moving average is 27.00, which suggests IMVT is a Sell.
              What is IMVT’s 200-day moving average?
              IMVT’s 200-day moving average is 28.56, which suggests IMVT is a Sell.
                What is IMVT’s Williams % R (14)?
                IMVT’s Williams % R (14) is -50.86, which suggests IMVT is a Buy.
                  What is IMVT’s CCI (14)?
                  IMVT’s CCI (14) is -66.44, which suggests IMVT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis